NTRK1 and colorectal carcinoma: An NTRK1 fusion was thus identified in 7/62 (11.3%) of the dMLH1/BRAFV600Ewt, in 7/43 (16.3%) of the dMLH1/BRAFV600Ewt/MLH1ph and in 7/30 (23.3%) of the dMLH1/BRAFV600Ewt/MLH1ph/RASwt CRC samples.